Mealey's PI/Product Liability - After Winning Verdict Cut, Novartis Will Still Appeal Zometa Jaw Verdict

Mealey's PI/Product Liability - After Winning Verdict Cut, Novartis Will Still Appeal Zometa Jaw Verdict

ORLANDO, Fla. - A month after getting a Zometa medical expenses verdict reduced from $300,000 to $11,899, Novartis Pharmaceuticals Corp. on March 21 told a Florida federal court that it is appealing the entire $1 million verdict, most of which is punitive damages (Nancy Guenther, et al. v. Novartis Pharmaceutical Corporation, No. 6:08-31, M.D. Fla., Orlando Div.).

Find full version on lexis Advance®
Access this news story on lexis.com®